Tempest Therapeutics Stock Price on July 2, 2024
| TPST Stock | USD 0.83 0.05 6.10% |
Below is the normalized historical share price chart for Tempest Therapeutics extending back to November 12, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Tempest Therapeutics stands at 0.83, as last reported on the 27th of December, with the highest price reaching 0.83 and the lowest price hitting 0.83 during the day.
If you're considering investing in Tempest Stock, it is important to understand the factors that can impact its price. Tempest Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11% return per unit of risk over the last 3 months. Tempest Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Tempest Therapeutics' Coefficient Of Variation of (1,334), risk adjusted performance of (0.05), and Variance of 28.44 to confirm the risk estimate we provide.
At this time, Tempest Therapeutics' Common Stock Total Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 70.9 M in 2024, whereas Capital Stock is likely to drop slightly above 11.3 K in 2024. . At this time, Tempest Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.06 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (2.60) in 2024. Tempest Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of November 2012 | 200 Day MA 2.0897 | 50 Day MA 0.947 | Beta (2.78) |
Tempest |
Sharpe Ratio = -0.1102
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TPST |
Estimated Market Risk
| 5.43 actual daily | 48 52% of assets are more volatile |
Expected Return
| -0.6 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tempest Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tempest Therapeutics by adding Tempest Therapeutics to a well-diversified portfolio.
Price Book 3.2637 | Book Value 1.214 | Enterprise Value 33 M | Enterprise Value Ebitda 0.3057 | Shares Float 21.7 M |
Related Headline
Akari Therapeutics Headline on 2nd of July 2024
Acquisition by Hashad Mohamed Wael Ahmed of 5000000 shares o... by Hashad Mohamed Wa'el Ahmed
Filed transaction by Akari Therapeutics PLC Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Tempest Therapeutics Valuation on July 2, 2024
It is possible to determine the worth of Tempest Therapeutics on a given historical date. On July 2, 2024 Tempest was worth 2.13 at the beginning of the trading date compared to the closed value of 2.12. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Tempest Therapeutics stock. Still, in general, we apply an absolute valuation method to find Tempest Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tempest Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Tempest Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.15 | 2.18 | 2.08 | 2.14 | 582,999 | |
07/02/2024 | 2.13 | 2.19 | 2.08 | 2.12 | 541,545 |
| 2.12 | 2.16 | 2.10 | 2.11 | 390,611 |
| Backtest Tempest Therapeutics | | | Tempest Therapeutics History | | | Tempest Therapeutics Valuation | Previous | Next |
Tempest Therapeutics Trading Date Momentum on July 2, 2024
| On July 03 2024 Tempest Therapeutics was traded for 2.11 at the closing time. The top price for the day was 2.16 and the lowest listed price was 2.10 . The trading volume for the day was 390.6 K. The trading history from July 3, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 0.47% . The trading price change against the current closing price is 3.77% . |
Tempest Therapeutics Fundamentals Correlations and Trends
By evaluating Tempest Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Tempest Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Tempest financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Tempest Therapeutics Stock history
Tempest Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tempest is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tempest Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tempest Therapeutics stock prices may prove useful in developing a viable investing in Tempest Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 15.4 M | 16.2 M | |
| Net Loss | -25.5 M | -26.7 M |
Tempest Therapeutics Quarterly Net Working Capital |
|
Tempest Therapeutics Stock Technical Analysis
Tempest Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Tempest Therapeutics Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
Tempest Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Tempest Therapeutics December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Tempest Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tempest Therapeutics shares will generate the highest return on investment. By undertsting and applying Tempest Therapeutics stock market strength indicators, traders can identify Tempest Therapeutics entry and exit signals to maximize returns
Tempest Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tempest Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Tempest Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tempest to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | (0.31) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Tempest Stock Analysis
When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.